Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research
October 12, 2023 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
September 12, 2023 08:30 ET
|
Entera Bio Ltd.
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK, “OPKO”) have entered into a Research...
Vitamin D Testing Market Size & Share to Hit USD 1.06 billion by 2031, Expanding at a CAGR of 5.8% - Exclusive Report by Transparency Market Research
September 11, 2023 10:26 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vitamin D testing market is projected to flourish at a CAGR of 5.8% from 2022...
Entera Bio to Participate in Upcoming Investor Conferences
September 05, 2023 08:00 ET
|
Entera Bio Ltd.
JERUSALEM, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
August 11, 2023 16:05 ET
|
Rani Therapeutics, LLC
- Expansion of partnership with Celltrion for development of RT-105 to complement existing partnership for RT-111 - Appointment of Kate McKinley as Chief Business Officer - Presentation of three...
Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
August 11, 2023 16:05 ET
|
Entera Bio Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics to Participate in August Investor Conferences
August 04, 2023 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Orthopedic Fracture Repairing Implants for Osteoporosis Market anticipated to reach US$ 4.8 billion by 2031: TMR study
July 31, 2023 11:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global market for orthopedic fracture repairing implants for osteoporosis was estimated to have acquired a market valuation...
[Latest] Global Women’s Health Diagnostics Market Size/Share Worth USD 45.4 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 18, 2023 04:30 ET
|
Custom Market Insights
Austin, TX, USA, July 18, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Women’s Health Diagnostics Market Size, Trends and Insights By Application...
Bone Health Technologies to Present Clinical Data from Pivotal Trial of Wearable Treatment for Osteopenia in Post-Menopausal Women at Endo 2023
June 16, 2023 14:15 ET
|
Bone Health Technologies
CHICAGO, June 16, 2023 (GLOBE NEWSWIRE) -- Bone Health Technologies (BHT), a pioneer in health technologies for preventing and treating bone health diseases, is presenting pivotal trial data for...